Sold by: Next Move Strategy Consulting
Deployed on AWS
The global Molecular Farming Market is projected to reach a value of USD 578.4 million by the end of 2025. It is expected to continue expanding, climbing to USD 1,180.2 million by 2030, reflecting a robust CAGR of 15.3% from 2025 to 2030. Also referred to as the biopharming market, this sector is witnessing strong growth fueled by an aging global population, a rise in infectious diseases, and increased agricultural output.
Overview
The global Molecular Farming Market is projected to reach a value of USD 578.4 million by the end of 2025 and is expected to grow further to USD 1,180.2 million by 2030, registering a strong CAGR of 15.3% during the forecast period.
Download FREE Sample: https://www.nextmsc.com/molecular-farming-market-hc3336/request-sample
Market growth is being fueled by the expanding global geriatric population, which is increasing demand for affordable and effective biopharmaceuticals. Additionally, the rising prevalence of infectious diseases such as cancer, hepatitis, and Ebola is further accelerating the need for plant-based therapeutic solutions.
Increasing global crop production is also contributing to the market trend, providing a robust supply of plant biomass essential for biopharmaceutical manufacturing. However, regulatory hurdles remain a significant barrier. Agencies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Singapore Health Sciences Authority (HSA) enforce stringent safety, efficacy, and environmental regulations for genetically modified organisms (GMOs). These compliance requirements often lead to delayed commercialization and elevated costs, particularly affecting small and emerging firms, thereby limiting market expansion.
Despite these challenges, technological advancements are unlocking new opportunities. The integration of CRISPR-Cas9 gene-editing tools allows for precise plant modifications, enhancing production efficiency and yield. As CRISPR continues to advance, it not only streamlines the molecular farming process but also attracts investment, encouraging broader adoption of plant-based pharmaceutical solutions.
Inquire before buying: https://www.nextmsc.com/molecular-farming-market-hc3336/inquire-before-buying
North America dominates the global molecular farming market, supported by a rapidly aging population and a growing need for innovative therapeutics. Notably, the elderly demographic in Mexico is expected to rise by 108% by 2050, significantly boosting demand for vaccines and therapeutic proteins in the region.
Access full report - https://www.nextmsc.com/report/rugged-military-computers-market-ad3296
Key players in the industry are actively driving innovation and sustainability in both the biopharmaceutical and food production sectors. Companies such as Bright Biotech Ltd., Moolec Science SA, Miruku Ltd., Finally Foods Ltd., Elo Life Systems, Inc., Tiamat Sciences Corporation, Core Biogenesis SAS, IngredientWerks, Inc., Kyomei Ltd., ORF Genetics, BioBetter Ltd., Forte Protein, Inc., Bright Green Partners B.V., NewMoo Foods Ltd., and PoLoPo Ltd. are pursuing strategies like new product development and investment fundraising to reinforce their market leadership.
About Next Move Strategy Consulting:
Next Move Strategy Consulting is an independent and trusted third-party market intelligence provider committed to delivering high-quality market research reports. We assist multinational companies in gaining a competitive edge and expanding their industry presence by capturing a larger market share. Our research methodology combines primary research, secondary research, data mining, and data analytics to deliver reliable insights.
Over a decade, we have served over 1,000 global customers, including 90% of Fortune 500 companies. Our analysts continually monitor high-growth markets and identify hidden opportunities across various sectors. We offer top-quality syndicate and custom research reports across ten different industry verticals, catering to your unique business needs. Our industry-standard delivery solutions, from pre-consultation to after-sales services, ensure an exceptional client experience and support informed strategic decision-making.
Contact Us:
Next Move Strategy Consulting
E-Mail: info@nextmsc.com
Direct: +1-217-650-7991
Website: https://www.nextmsc.com/
Details
Delivery method
Deployed on AWS
New
Introducing multi-product solutions
You can now purchase comprehensive solutions tailored to use cases and industries.
Features and programs
Financing for AWS Marketplace purchases
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
Pricing
This product is available free of charge. Free subscriptions have no end date and may be canceled any time.
Additional AWS infrastructure costs may apply. Use the AWS Pricing Calculator to estimate your infrastructure costs.
Vendor refund policy
All sales are final; no refunds or returns are accepted. Our reports include sensitive, researched data from various sources, including industry experts and paid services. We ensure confidentiality and offer customization at an additional cost. Please review our terms before purchase. For inquiries, contact customer service.
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA) .
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Additional details
You will receive access to the following data sets.
Data set name | Type | Historical revisions | Future revisions | Sensitive information | Data dictionaries | Data samples |
|---|---|---|---|---|---|---|
NMSC_MarketResearch | All historical revisions | All future revisions | Not included | Not included |
Resources
Vendor resources
Similar products
GROMACS is an open-source molecular dynamics engine, offered here with additional charges for configuration, automation, and technical support. This AMI delivers a fully optimized HPC environment with GPU acceleration, MPI support, scientific libraries, VMD visualization, BioBB workflow automation modules, and Amazon DCV remote access ideal for high-performance molecular simulation and analysis.
SG4D100M is a state-of-the-art molecular foundation model that revolutionizes drug discovery and chemical development. Built on advanced transformer architecture with SE(3) invariance, it enables accurate molecular property prediction and structural analysis across pharmaceutical, specialty chemical, and agricultural applications.
This AMI allows users to run a proprietary Freecurve Labs MD package to predict various properties of different molecular ensembles: proteins, RNAs, DNAs, ligands, etc.
Nach01 is a language foundation model designed for AI-driven drug discovery, enabling fine-tuning and efficient molecular property prediction to accelerate your DMTA cycle.
Get to the winning molecule faster! Discover drugs, chemicals, catalysts, and materials faster and at lower cost. This modern ab initio SaaS platform allows high accuracy molecular simulations at unprecedented speeds. Unrivaled performance, accuracy, and capabilities make this platform an indispensable part of the discovery process.